Leshchiner, Ignaty http://orcid.org/0000-0001-8942-9265
Mroz, Edmund A. http://orcid.org/0000-0002-1014-7853
Cha, Justin http://orcid.org/0000-0001-6026-2211
Rosebrock, Daniel
Spiro, Oliver
Bonilla-Velez, Juliana
Faquin, William C. http://orcid.org/0000-0002-9043-7171
Lefranc-Torres, Armida
Lin, Derrick T.
Michaud, William A.
Getz, Gad http://orcid.org/0000-0002-0936-0753
Rocco, James W. http://orcid.org/0000-0001-5312-0303
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (R01DE022087, R01DE022087, R01DE022087, R01DE022087)
Article History
Received: 31 October 2021
Accepted: 24 February 2023
First Online: 20 April 2023
Competing interests
: G.G. receives research funds from IBM and Pharmacyclics and is an inventor on patent applications related to MSMuTect, MSMutSig, MSIDetect, POLYSOLVER and TensorQTL. G.G. is a founder of, consultant for and holds privately held equity in Scorpion Therapeutics. I.L. is a consultant for PACT Pharma, Inc., and a Board member, scientific adviser and consultant and holds privately held equity in ennov1, LLC and NoRD Bio, Inc. The remaining authors declare no competing interests.